# Dextromethorphan Pediatric Acute Cough Study

> **NCT02651116** · PHASE4 · TERMINATED · sponsor: **Pfizer** · enrollment: 131 (actual)

## Conditions studied

- Cough

## Interventions

- **DRUG:** Dextromethorphan Hydrobromide
- **DRUG:** Placebo
- **DEVICE:** Cough recording device

## Key facts

- **NCT ID:** NCT02651116
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02-25
- **Primary completion:** 2020-03-19
- **Final completion:** 2020-03-19
- **Target enrollment:** 131 (ACTUAL)
- **Why stopped:** The study was prematurely discontinued due to slow enrollment during the 2019/2020 cold season. No safety or efficacy concerns led to the decision to terminate
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02651116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02651116, "Dextromethorphan Pediatric Acute Cough Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02651116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*